Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 53.97x is 105% above its 5-year average of -1131.70x, around the middle of its 5-year range (-2389.99x–2929.62x).
95.73% below its 12-month average of 1264.03x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): 32.54x.
INTEREST COVERAGE RATIO
53.97x
INTEREST COVERAGE RATIO AVG TTM
1264.03x
INTEREST COVERAGE RATIO AVG 3Y
-698.95x
INTEREST COVERAGE RATIO AVG 5Y
-1131.70x
INTEREST COVERAGE RATIO AVG 10Y
-1140.25x
INTEREST COVERAGE RATIO AVG 15Y
-1435.54x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-95.73%
CURRENT VS 3Y AVG
+107.72%
CURRENT VS 5Y AVG
+104.77%
CURRENT VS 10Y AVG
+104.73%
CURRENT VS 15Y AVG
+103.76%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
+1381.95%
vs the sector median at left
CorMedix Inc.
Market Cap
$562.85M
Interest Coverage Ratio
53.97x
TTM Avg
1264.03x
3Y Avg
-698.95x
5Y Avg
-1131.70x
Market Cap
$559.96M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$573.38M
Interest Coverage Ratio
-4.07x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$580.12M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$552.97M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$548.89M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$540.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$590.58M
Interest Coverage Ratio
-4.84x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CorMedix Inc. (CRMD) | $562.85M | 53.97x | 1264.03x | -698.95x | -1131.70x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $559.96M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -4.07x | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $580.12M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $552.97M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $548.89M | N/A | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $540.75M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $538.28M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $590.58M | -4.84x | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $542.67M | -69.85x | N/A | N/A | N/A |
Interest Coverage
54.0x
Debt/Equity
0.31
Current Ratio
2.56
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | 32.54x |
| 2025-09-30 | 54.15x |
| 2025-06-30 | 2929.62x |
| 2025-03-31 | 2011.12x |
| 2024-12-31 | 1292.70x |
| 2024-09-30 | -328.50x |
| 2024-06-30 | -2333.87x |
| 2024-03-31 | -1698.45x |
| 2023-12-31 | -2389.99x |
| 2023-09-30 | -798.24x |
| 2023-06-30 | -2017.53x |
| 2023-03-31 | -1255.38x |
| 2022-12-31 | -955.93x |
| 2022-09-30 | -793.29x |
| 2022-06-30 | -2298.59x |
| 2022-03-31 | -1307.62x |
| 2021-12-31 | -1446.62x |
| 2021-09-30 | -1591.70x |
| 2021-03-31 | -1390.92x |
| 2020-12-31 | -1143.30x |
| 2020-09-30 | -846.64x |
| 2020-06-30 | -645.11x |
| 2020-03-31 | -894.16x |
| 2019-12-31 | -856.69x |
| 2019-09-30 | -29.99x |
| 2019-06-30 | -18.05x |
| 2019-03-31 | -16.30x |
| 2018-03-31 | -5439.84x |
| 2017-12-31 | -3656.29x |
| 2017-09-30 | -2851.24x |
| 2016-12-31 | -20154.84x |
| 2016-06-30 | -119810.24x |
| 2016-03-31 | -4295.70x |
| 2015-12-31 | -1738.07x |
| 2015-09-30 | -2928.88x |
| 2015-06-30 | -1119.88x |
| 2015-03-31 | -6399.21x |
| 2014-12-31 | -3982.58x |
| 2014-09-30 | -3369.87x |
| 2014-06-30 | -3683.66x |
| 2014-03-31 | -6310.86x |
| 2013-12-31 | -50.39x |
| 2013-09-30 | -4.05x |
| 2013-06-30 | -1.96x |
| 2013-03-31 | -1.85x |
| 2012-12-31 | -2.33x |
| 2012-09-30 | -26.00x |
| 2010-03-31 | -1.21x |
| 2009-12-31 | -6.97x |
| 2009-09-30 | -1.93x |
| 2009-06-30 | -1.13x |
| 2009-03-31 | -1.24x |
